Author profile Dana Cole, BScPharm, hide first letter Letters / December 2012 Re: BC Health Authorities Pharmacy and Therapeutics Committee The premise for Dr Miller’s letter in the September issue [BCMJ 2012;54:327] appears to be a recent decision by the BC Health Authorities Pharmacy & Therapeutics (BCHA P&T) committee regarding dabigatran,... Read More
Letters / December 2012 Re: BC Health Authorities Pharmacy and Therapeutics Committee The premise for Dr Miller’s letter in the September issue [BCMJ 2012;54:327] appears to be a recent decision by the BC Health Authorities Pharmacy & Therapeutics (BCHA P&T) committee regarding dabigatran,... Read More